The Patent Finder

Athena Diagnostics, Inc.

Also on record
Records under this name other than the patents Athena Diagnostics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.

Back to Athena Diagnostics, Inc.

PatentTitleStatus Expires Confidence
US 7,273,701Compositions and methods for genetic analysis of polycystic kidney disease
Term ended
Term ended Nov 8, 2023 · From the USPTO record
Term endedTerm ended Nov 8, 2023From the USPTO record
US 7,119,186Application of Aprataxin Gene to Diagnosis and Treatment for Early-Onset Spinocerebellar Ataxia (EAOH)
Term ended
Term ended Apr 22, 2023 · High confidence
Term endedTerm ended Apr 22, 2023High confidence
US 6,916,619Compositions and Methods for Genetic Analysis of Polycystic Kidney Disease
Term ended
Term ended Mar 10, 2023 · High confidence
Term endedTerm ended Mar 10, 2023High confidence
US 7,824,860Application of Aprataxin Gene to Diagnosis and Treatment for Early-Onset Spinocerebellar Ataxia (EAOH)
Lapsed on the fee record
Ended Nov 2, 2022 · High confidence
Lapsed on the fee recordEnded Nov 2, 2022High confidence
US 7,521,190Compositions and methods for genetic analysis of polycystic kidney disease
Lapsed on the fee record
Ended Apr 21, 2021 · From the USPTO record
Lapsed on the fee recordEnded Apr 21, 2021From the USPTO record
US 6,599,756Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups
Term ended
Ended no later than Jul 27, 2020 · From the USPTO record
Term endedEnded no later than Jul 27, 2020From the USPTO record
US 6,951,763Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups
Term ended
Term ended Jul 27, 2020 · From the USPTO record
Term endedTerm ended Jul 27, 2020From the USPTO record
US 6,824,999Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups
Term ended
Term ended May 5, 2020 · From the USPTO record
Term endedTerm ended May 5, 2020From the USPTO record
US 6,485,960Polycystic kidney disease 1 gene and uses thereof
Term ended
Term ended Nov 26, 2019 · From the USPTO record
Term endedTerm ended Nov 26, 2019From the USPTO record
US 7,799,529Nephrin gene and protein
Lapsed on the fee record
Ended Sep 21, 2018 · From the USPTO record
Lapsed on the fee recordEnded Sep 21, 2018From the USPTO record
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited